{{Rsnum
|rsid=11168287
|Gene=VDR
|Chromosome=12
|position=47891631
|Orientation=plus
|GMAF=0.4954
|Gene_s=VDR
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 30.2 | 52.4 | 17.5
| HCB | 18.6 | 46.5 | 34.9
| JPT | 11.1 | 53.3 | 35.6
| YRI | 53.2 | 40.3 | 6.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 18.6 | 46.5 | 34.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21365644
|Title=Vitamin D receptor polymorphisms in patients with cutaneous melanoma
|OA=1
}}

{{PMID Auto
|PMID=19454612
|Title=Vitamin D pathway gene variants and prostate cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=19956101
|Title=Overview of the Rapid Response data.
|OA=1
}}

{{PMID Auto
|PMID=19956103
|Title=Association analyses of the vitamin D receptor gene in 1654 families with type I diabetes.
|OA=1
}}

{{PMID Auto
|PMID=22892281
|Title=Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}